Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05183009Not ApplicableUnknown

eXciteOSA for Treatment of Mild Obstructive Sleep Apnea

Role: lead

NCT05252156Not ApplicableCompleted

eXciteOSA for Treatment of Moderate Obstructive Sleep Apnea

Role: lead

NCT04392765Not ApplicableUnknown

Efficacy of Intra-oral Neuromuscular Stimulation Training on Snoring and Mild Sleep Apnoea

Role: lead

NCT03829956Not ApplicableCompleted

Intraoral Tongue Stimulation for Treatment of Primary Snoring

Role: lead

All 4 trials loaded